PI3K/AKT/mTOR pathway and autophagy regulator genes in paranasal squamous cell carcinoma metastasis

Cigir Biray Avci1, Baha Sezgin2, Bakiye Goker Bagca3

  • 1Medical Biology Department, Ege University School of Medicine, Bornova, 35100, Izmir, Turkey.

Insights

This study reveals that increased expression of the PI3K/AKT/mTOR pathway and autophagy genes may drive metastasis in paranasal sinus cancers. These findings offer new insights into the molecular mechanisms of this rare cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Paranasal sinus carcinomas are rare cancers with limited understanding of their molecular drivers.
  • The PI3K/AKT/mTOR pathway and autophagy are implicated in head and neck cancers but not specifically studied in paranasal sinus carcinomas.

Purpose of the Study:

  • To investigate the gene expression of the PI3K/AKT/mTOR pathway and autophagy in paranasal sinus squamous cell carcinoma.
  • To determine if these molecular changes correlate with the presence or absence of neck metastasis.

Main Methods:

  • Gene expression analysis using qRT-PCR on tissue samples from eight paranasal sinus carcinoma patients.
  • Evaluation of gene expression levels using the 2-∆∆Ct method and fold change calculations.

Main Results:

  • Significantly increased expression of PI3K/AKT/mTOR pathway and autophagy-related genes was observed.
  • Elevated gene expression was particularly pronounced in neck metastasis tissues compared to primary tumors.

Conclusions:

  • Upregulation of the PI3K/AKT/mTOR pathway and autophagy genes may contribute to the metastatic potential of paranasal sinus squamous cell carcinomas.
  • This is the first transcriptome-level assessment of autophagy genes in paranasal sinus cancer, highlighting potential targets for future research.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.5K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K